2m 2m 2m 2m 2m 2m - S&P 600$1,709.07
2m
Regeneron Pharma (REGN)
NASDAQ
$957.03+$1.56 (+0.16%)
Price as of Nov 13, 2026 7:55 PM EST- $96.7BMarket Cap
- 38.48%1-Year Change
- BiotechnologyIndustry
Regeneron Pharma (REGN)
$957.03+$1.56 (+0.16%)
REGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $955.47 | ||
Change | +$4.28 (+0.45%) | ||
Open | $952.47 | ||
High | $961.94 | ||
Low | $942.00 | ||
Previous Close | $951.19 | ||
Volume | 1,165,718 | ||
30-Day Average Volume | 980,060 | ||
1-Week Change | 5.65% | ||
1-Month Change | 26.87% | ||
1-Year Change | 38.48% | ||
3-Year Change | 21.06% | ||
5-Year Change | 52.80% | ||
Fundamentals | |||
Shares Outstanding | 101.6M | ||
Total Assets | $44.4B | ||
Market Cap | $96.7B | ||
Enterprise Value | $95.0B | ||
Period: QTR TTM FY | |||
Revenue | $1.0B | ||
Net Income | $1.9B | ||
Free Cash Flow | $1.5B | ||
EBIT | $2.3B | ||
EBITDA | $2.4B | ||
Net Working Capital | $14.6B | ||
EPS | $18.45 | ||
Enterprise Value/EBITDA | 39 | ||
Enterprise Value/Revenue | 95 | ||
P/B | 3 | ||
P/E | 52 | ||
PEG | 1 | ||
Price/Free Cash Flow | 65 | ||
Price/Operating Cash Flow | 54 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 0.39% | ||
Trailing Annual Dividend Yield | 0.39% | ||
Ex-Dividend Date | 11/20/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield